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reactive protein Levels are Affected
Abstract
Background: Research has shown that increased levels of C-reactive protein (CRP) are found in patients
with heart disease, diabetes, and Alzheimer disease. In fact, some studies demonstrate that CRP may even
have causal effects. The purpose of this systematic review is to look at the effects of whole diet on serum CRP
levels. By simply changing what foods we eat, or what foods we don’t eat, is it possible to reduce our risk of
these diseases?
Method: An exhaustive search of available medical literature was conducted using Medline-OVID, CINAHL,
and Google Scholar using the keywords: C-reactive protein, diet, food habits, inflammation, anti-
inflammatory, and cytokines. Inclusion and exclusion criteria were applied. The bibliographies of the articles
were further searched for relevant sources. Relevant articles were assessed for quality using the Grading of
Recommendations, Assessment, Development and Evaluation (GRADE).
Results: Six studies met inclusion criteria and were included in this systematic review. A randomized, single
blinded-controlled trial with 180 patients with metabolic syndrome demonstrated a statically significant drop
in CRP levels in participants who were instructed to eat a Mediterranean-style diet compared to the control
group. A second randomized study with 66 patients with moderate to severe rheumatoid arthritis (RA)
demonstrated that patients who ate a gluten-free, vegan diet had statistically lower CRP levels than individuals
who ate a non-vegan diet. A cross-sectional study of 732 women demonstrated that women who ate a more
“prudent” diet compared to a more “western” one had statistically significant lower levels of CRP. A second
cross-sectional study of 3042 men and women demonstrated that a greater adherence to a Mediterranean diet
showed statistically significant decreases in serum CRP levels. A third cross-sectional study of 5089 patients
demonstrated that levels of CRP were positively associated with consumption of fats and processed meats and
inversely associated with ingestion of whole grains and fruit. An interventional study with 24 participants with
moderate to severe RA demonstrated that there was no statistically significant drop in CRP levels in
participants who consumed a very low-fat, vegan diet.
Conclusion: Serum levels of CRP appear to have a correlation to diet. A recommendation can be made to put
all patients on a Mediterranean style diet regardless of health status, as it is a simple, low-cost, self-
administered, and safe intervention. Furthermore, it can be recommended that patients with RA be placed on
a vegan diet. Another consideration is if patients with RA are non-compliant with a vegan diet, then a
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NOTICE TO READERS 
 
This work is not a peer-reviewed publication.  The Master’s Candidate author of this 
work has made every effort to provide accurate information and to rely on authoritative 
sources in the completion of this work.  However, neither the author nor the faculty 
advisor(s) warrants the completeness, accuracy or usefulness of the information provided 
in this work.  This work should not be considered authoritative or comprehensive in and 
of itself and the author and advisor(s) disclaim all responsibility for the results obtained 
from use of the information contained in this work.  Knowledge and practice change 
constantly, and readers are advised to confirm the information found in this work with 
other more current and/or comprehensive sources. 
 
The student author attests that this work is completely his/her original authorship and that 
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Abstract   
Background: Research has shown that increased levels of C-reactive protein (CRP) are 
found in patients with heart disease, diabetes, and Alzheimer disease. In fact, some studies 
demonstrate that CRP may even have causal effects. The purpose of this systematic review is 
to look at the effects of whole diet on serum CRP levels. By simply changing what foods we 
eat, or what foods we don’t eat, is it possible to reduce our risk of these diseases? 
 
 
Method: An exhaustive search of available medical literature was conducted using Medline-
OVID, CINAHL, and Google Scholar using the keywords: C-reactive protein, diet, food 
habits, inflammation, anti-inflammatory, and cytokines. Inclusion and exclusion criteria were 
applied. The bibliographies of the articles were further searched for relevant sources. 
Relevant articles were assessed for quality using the Grading of Recommendations, 
Assessment, Development and Evaluation (GRADE).  
 
Results: Six studies met inclusion criteria and were included in this systematic review. A 
randomized, single blinded-controlled trial with 180 patients with metabolic syndrome 
demonstrated a statically significant drop in CRP levels in participants who were instructed 
to eat a Mediterranean-style diet compared to the control group. A second randomized study 
with 66 patients with moderate to severe rheumatoid arthritis (RA) demonstrated that patients 
who ate a gluten-free, vegan diet had statistically lower CRP levels than individuals who ate 
a non-vegan diet. A cross-sectional study of 732 women demonstrated that women who ate a 
more “prudent” diet compared to a more “western” one had statistically significant lower 
levels of CRP. A second cross-sectional study of 3042 men and women demonstrated that a 
greater adherence to a Mediterranean diet showed statistically significant decreases in serum 
CRP levels. A third cross-sectional study of 5089 patients demonstrated that levels of CRP 
were positively associated with consumption of fats and processed meats and inversely 
associated with ingestion of whole grains and fruit. An interventional study with 24 
participants with moderate to severe RA demonstrated that there was no statistically 
significant drop in CRP levels in participants who consumed a very low-fat, vegan diet.  
 
Conclusion: Serum levels of CRP appear to have a correlation to diet. A recommendation 
can be made to put all patients on a Mediterranean style diet regardless of health status, as it 
is a simple, low-cost, self-administered, and safe intervention. Furthermore, it can be 
recommended that patients with RA be placed on a vegan diet. Another consideration is if 
patients with RA are non-compliant with a vegan diet, then a recommendation that they try a 
Mediterranean style diet is reasonable.   
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The Effect of Whole Diet on Inflammation: A Close Look at How C-reactive protein 
Levels are Affected  
BACKGROUND 
Currently heart disease is the leading cause of death in the United States, killing about 
600 000 people yearly.1As of 2004, the World Health Organization (WHO) estimated that 
347 million people worldwide were suffering from diabetes mellitus (DM) and projected that 
deaths related to diabetes would increase by two thirds between 2008 and 2030.2 There are 
currently 5.4 million Americans suffering with Alzheimer disease (AD).3 AD is the sixth 
leading cause of death in the United States, and, currently, there are no known ways to 
prevent, slow, or cure AD.3 
 Current research is showing the importance of biomarkers of inflammation, mainly C-
reactive protein (CRP), in connection with both heart disease and type II DM.4 The role of 
CRP is to help activate the complement system (part of the innate immune system).5 CRP is 
an acute phase plasma protein, synthesized by the liver, which is evidenced by several 
hundredfold increases in response to tissue injury. This extreme production by the liver gives 
credence to the importance of CRP’s role in the body’s response to injury. Similarly, a lack 
of CRP in the body at times of health indirectly indicates this same principle.6 CRP is most 
commonly used to monitor progress and response to therapy in patients with conditions such 
as infection and inflammatory disease.  One reason that CRP is so widely used is that levels 
do not seem to be influenced by the body’s natural circadian rhythm7. Also, CRP is easily 
and accurately measured in a laboratory8 and is easy for clinicians to get results.  
One study4  found that elevated levels of CRP help predict the development of type II 
DM even after adjustment for obesity, clinical risk factors, and fasting insulin levels. In that 
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same study, interleukin 6 (IL-6) was also found to be a predictor of developing type II DM 
but in lower magnitude. While some studies9,10 have shown a positive correlation between 
obesity and elevated levels of CRP, other studies11,12 have found that CRP levels remain a 
predictor of developing type II DM independent of obesity, which suggests an independent 
role in CRP in the developing of type II DM.  
Furthermore, inflammation plays a key role in the development of atherosclerotic 
disease.13,14 In particular, inflammation plays a key role in the pathogenesis and evolution of 
the atheroma in atherolsclerosis, but also in the disruption of the atherosclerotic plaque, 
which can lead to a myocardial infarction (MI), cerebrovascular accident (CVA), stroke, 
angina, or gangrene.13,15 
 In addition to an increased risk for type II DM and coronary heart disease (CHD), 
elevated CRP levels are now beginning to show neurochemical changes linked to the 
development of cognitive impairment later in life even evidenced in some middle-aged adults 
who are cognitively intact.16 Another study17 showed that decreases in executive functioning, 
including psychomotor speed and attention, were associated with elevated levels of CRP, but 
that memory and linguistic skills were not associated with the elevated levels. In addition to 
CRP, elevated levels of interleukin-6 (IL-6) have been shown to have negative effects on 
cognitive function.18 Studies19,20 also have shown a that patients with AD have increased 
levels of inflammatory biomarkers, including IL-6, in serum and cerebrospinal fluid (CSF).   
In a time in which more people are suffering and dying from CHD, DM, and 
cognitive decline, research continues to look at possible causes, and diet may have an 
important role. A practitioner's goal should be to prevent these debilitating illnesses. With 
these markers of inflammation being linked to type II DM, CHD, and cognitive decline, what 
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can be done? The purpose of this review is to look at the effects of the food we eat in 
correlation with levels of CRP.  
METHODS 
  An exhaustive search of available medical literature was conducted using Medline-
OVID, CINAHL, and Google Scholar using the keywords: C-Reactive protein, diet, 
inflammation, anti-inflammatory, and cytokines. The search was then narrowed to include 
only English language articles and studies performed only on humans. Articles were included 
only if they examined whole diet, not individual components of diet, and articles must have 
diet as the central component of intervention. Articles were excluded if they did not evaluate 
levels of CRP or if they demanded monetary compensation in order to obtain them. The 
bibliographies of articles were further searched for relevant sources. Relevant articles were 
assessed for quality using the Grading of Recommendations, Assessment, Development and 
Evaluation (GRADE).21  
RESULTS 
 Six studies met inclusion criteria and were included in this systematic review 
including: two randomized control trials, three observations studies, and one interventional 
study. (See Figure 1)  
 
Esposito et al  
 In this randomized control trial,22 investigators assessed the effects of the 
Mediterranean diet on endothelial function and vascular inflammatory markers in patients 
with metabolic syndrome.22 
 In total 220 participants were assessed for eligibility. After inclusion and exclusion 
criteria were applied, 180 participants were randomized using a computer-generated random 
number sequence. Allocation was concealed in sealed study folders that were held in a 
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central, secured location until after informed consent was obtained. Staff members who were 
involved in the intervention group were not blinded, thus the study was partially blinded. The 
laboratory staff members were blinded. In order to be included in the study, participants had 
to meet three of the following five criteria: abdominal adiposity (waist circumference >102 
cm in men or >88 cm in women), low levels of serum high-density lipoprotein cholesterol 
(<40mg/dL in men or <50mg/dL in women), hypertriglyceridemia (triglycerides levels of 
150mg/dL or greater), elevated blood pressure (130/85 or greater), and impaired glucose 
homeostasis (fasting plasma glucose concentrations of 100mg/dL or greater). Participants 
were excluded if they had history of CVD, psychiatric problems, alcohol abuse, smoking, or 
if they took any medication.22 
 Investigators randomly assigned the 180 participants into either the control or the 
interventional diet group. At the beginning of the trial, both groups were prognostically 
balanced. The interventional diet group, the group following the Mediterranean style diet, 
was given education on how to reduce dietary calories, goal setting, and self-monitoring 
using food diaries. Dietary advice was also provided. Participants in the interventional group 
were instructed to eat the following: 50-60% carbohydrates, 15-20% protein, total fat, <30%, 
saturated fat <10%, cholesterol consumption, <300mg/day, consume 250-300 g of fruit/day, 
125-150 g of vegetables/day, 25-50 g of walnuts/day, 400 g of whole grains/day, and 
increase how much olive oil they consumed daily. Participants in the control diet were given 
oral and written information about healthy food choices. The control diet consisted of: 50-
60% carbohydrates, 15-20% protein, and total fat <30%. Participants in both groups had 
monthly follow-ups for the first year and bimonthly meetings in the second year. Compliance 
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was measured by how often participants attended the meetings. All participants were 
encouraged to increase their level of physical activity. The study lasted 24 months.22 
 Blood was collected at baseline. Endothelial function was assessed using L-arginin 
test. Investigators measured the following inflammatory biomarkers: hs-CRP, IL-6, IL-7, and 
IL-18.22 
 At the conclusion of the 24 months, sixteen participants, 8 from the interventional 
group and 8 from the control group, had dropped out. Participants in the interventional diet 
group had decreased body weight, BMI, blood pressure (BP), glucose levels, total 
cholesterol, and triglycerides. Also, participants in the interventional group had statistically 
significantly decreased IL-6, IL-7, IL-18, and hs-CRP when compared to the control group. 
Of the original 90 participants in the interventional group, only 40 could be classified as still 
having metabolic syndrome at the conclusion of the study. Conversely, 78 participants in the 
control group, at the conclusion of the 24-month study, could still be classified as having 
metabolic syndrome. This calculates to a relative risk of 0.51 and a number-needed-to-treat 
of 3.22 
 The only limitation of this study discussed by the authors was whether individual 
components of the diet account for the results or if the results are due to the diet as a whole.22 
Elkan et al 
 In this randomized control trial,23 investigators measured the effects of a vegan diet in 
patients with RA, on blood lipids, oxidized low-density lipoprotein (oxLDL), and natural 
atheroprotective antibodies against phosphorylcholine (anti-PCs).  Participants were invited 
to enroll in the studies if they were between 20-69 years old, had RA for 2-10 years, had 
never tried dietary intervention, and had active disease. Participants were excluded if they 
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had a current malignancy; CV, pulmonary, or renal disease; and DM. In total, 66 patients 
were admitted into the study. Patients who were on anti-inflammatory, oral glucocorticoids, 
or anti-rheumatic medications were allowed to continue. At the start of the trial, the two 
groups were not prognostically balanced. The vegan group had a total of 30 participants, of 
which 18 were on glucocorticoids. However, out of the 28 patients in the non-vegan group, 
only nine were on glucocorticoids. 
 Patients were randomly assigned to ether a gluten-free vegan diet or a non-vegan diet. 
The study lasted 1 year. Thirty-eight patients were entered into the gluten-free vegan diet, 
which consisted of 10% protein, 60% carbohydrates, and 30% fats. It contained vegetables, 
nuts, and fruit, and no animal products. Twenty-eight patients were assigned to the non-
vegan diet. This diet was described as 10-15% protein, 55-60% carbohydrates, and saturated 
fat was limited to <10%. Five or more daily servings of fruits and vegetables were suggested 
while increasing starch and complex, whole-grain carbohydrates when possible. Each group 
received instructions and education pertaining to their corresponding diet. Follow-ups for 
each group took place at 3, 6, 9, and 12 months. Blood samples were collected at baseline, 3 
months, and at 1 year. ESR, CRP, hemoglobin, WBC, serum albumin, total cholesterol, low 
density lipoprotein (LDL), high density lipoprotein (HDL), and triglycerides (TG) were 
measured. Disease activity was assessed using the Disease Activity Score in 28 joints 
(DAS28).23 
 Of the 38 participants who started in the gluten-free, vegan diet, 30 completed three 
months with an additional 8 dropping out before the completion of the 12-month study. All 
twenty-eight participants in the non-vegan diet completed at least three months. Results 
showed that the participants in the vegan group lost more weight (p<.001) and reduced their 
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BMI (p<.001). The non-vegan group also lost weight and reduced their BMI but both 
reductions were seen as non-significant changes. CRP levels in the vegan group dropped 
dramatically from baseline to 12 months (p=.008). CRP levels did also decrease in the non-
vegan group, but it was not seen as significant (p=.28).23 
 One limitation, as discussed by the authors, was the small number of participants 
(n=66). Second limitation discussed was compliance. Compliance was monitored by 
regularly scheduled follow-ups and dietary records. Third limitation was allowing the 
changes in anti-rheumatic medication during the trial (two patients in the vegan group and 
one in the non-vegan group started anti-rheumatic therapy during the study period), but was 
determined too limited to have an impact on the results.23 
Lopez-Garcia et al  
 
 In this cross-sectional study,24 the investigators examined different diets on markers 
of inflammation and endothelial dysfunction. The subjects of the study were from the 
Nurses’ Health Study cohort. The trial enrolled 732 women who met the following eligibility 
criteria: free from coronary vascular disease (CVD), cancer, or DM.24 
 In 1986 and 1990, a food frequency questionnaire (FFQ) was mailed to all the 
participants. The FFQ included questions on 116 food items, and quantified portions using 
natural portions or standard weight and volume. For each food item, participants were asked 
to indicate the how often they consumed the food over the past year by checking frequency 
categories, nine total choices, which ranged from “almost never” to “>/= 6 times/day.” The 
selected frequency category for each food item was converted to a value in number of 
servings per day. Certain considerations were taken for particular single food items such as, 
but not limited to, pizza, soup, coffee, and eggs. Calculations of averages of food were done 
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in 1986 and 1990. Investigators also assessed cigarette smoking, body weight, body mass 
index (BMI), and physical activity.24 
 Blood was collected between 1989-1990. For collection, participants were sent home 
phlebotomy kits in order to provide the sample. Of these samples, 97% were returned to 
investigators within 26 hours of being drawn. Samples were centrifuged and kept frozen with 
liquid nitrogen until analysis. The following markers were measured: CRP, IL-6, E-selectin, 
soluble intracellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion 
molecule-1 (sVCAM-1).24 
 Based on FFQ, investigators found two major dietary patterns. Pattern 1 was called 
the prudent pattern. This pattern was characterized by higher intake of fruits, legumes, 
vegetables, whole grains, fish, and poultry. Pattern 2 was called the Western pattern. This 
pattern was characterized by a higher intake of red meat, processed meat, refined grains, 
sweets, desserts, French fries, and high-fat dairy products. Each pattern was further broken 
down into quintiles, ranging from 1 to 5. Participants in quintile 5 were said to have the 
strictest adherence to the respected pattern.24 
 Investigators found that age-adjusted CRP levels and E-selectin levels decreased with 
increasing quintile of the prudent patterns. (See Table 5) On the other hand, CRP, IL-6, E-
selectin, sICAM-1, and sVCAM-1 showed increasing trends with increasing quintiles of the 
Western pattern.  The same was true even after adjustment for BMI, physical activity, 
smoking status, and average alcohol consumption.  Within the prudent pattern group, 
subjects in the highest quintile were more physically active, smoked less, had lower intake of 
saturated fat and trans fatty acids with higher intake in polyunsaturated fat, folate, and fiber 
when compared to subjects in the lowest quintile. Within the Western pattern group, subjects 
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in the highest quintile when compared to the lowest quintile had higher BMI, were more 
likely to smoke, less likely to exercise, had higher intake of saturated fats and trans fatty 
acids with lower intakes of folate and fiber.24  
 One limitation, as discussed by the authors, was the study design being cross-
sectional, which means that they cannot infer causality. Second limitation was the degree of 
error in the measurement of food consumption; however, the authors claim that the use of 
repeated measurement enabled them to reduce within-person random error. The third 
limitation was the factor analysis approach involved several arbitrary decisions. The final 
limitation discussed by the authors was that the study population, mostly white, highly 
educated women from the United States of America does not accurately reflect the general 
population.24 
Nettleton et al 
 In this cross-sectional study,25 investigators looked at the relations between dietary 
patterns and biochemical markers of inflammation and endothelial activation.  Participants in 
the study were taken from the Multi-Ethnic Study of Atherosclerosis (MESA). There were 
5089 total participants included from the MESA study in line with the following exclusion 
criteria: those currently taking oral steroids or currently taking anti-inflammatory asthma 
medication, those with DM, and those who did not provide sufficient and plausible dietary 
information.25 
 Investigators measured the following markers: CRP, IL-6, homocysteine, sICAM-1, 
and s E-selectin. Samples were collected at baseline, were stored and all processed in the 
same way, and were analyzed using the same machines.25 
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 Diet assessment of the previous year was done at baseline using a 120-item FFQ that 
included food and beverages. Serving size was recorded using the terms “small,” “medium,” 
and “large.” Frequency of consumption was also recorded using averages per day, week, or 
month. Frequency options ranged from “rare or never” to “>/=2 times/day” for foods and 
“>/=6 times/day” for beverages. In total, 630 participants were excluded due to unreliable 
dietary data.25 
 Investigators formed 47 food groups based on questions from the FFQ on the basis of 
similar nutrient characteristics or hypothesized biologic effects. Investigators also collected 
data on demographics, education, medications, smoking history, and physical activity. 
Height, weight, waist circumference, and BMI were also collected.25 
Four main dietary patterns were discerned. Dietary patterns were named according to 
the most dominant food groups in each of the 4 factor patterns. 
1 Pattern 1: fats and processed meats (greatest amount of “fats and oils,” “high-fat 
and processed meats,” “fried potatoes,” “salty snacks,” and “desserts.”) 
2 Pattern 2: vegetables and fish (greatest amount of various vegetable groups 
(“dark-yellow,” “cruciferous,” “other vegetables”), “fish,” and “soups.”) 
3 Pattern 3: beans, tomatoes, and refined grains (greatest amounts of “legumes,” 
“tomatoes,” “refined bread, rice, and pasta,” “high-fat cheeses and cheese and 
cream sauces,” and “avocados and guacamole.”) 
4 Pattern 4: whole grains and fruit (greatest amount of “whole-grain bread, rice, 
and pasta,” “fruit,” “seeds, nuts, and peanut butter,” “green leafy vegetables,” and 
“low-fat milk”).25 
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Investigators discovered that concentrations of CRP, IL-6, and homocysteine were 
positively associated with the fats and processed meats pattern and inversely associated with 
the whole grains and fruit pattern. Also, Pattern 2 (vegetables and fish) was inversely related 
to IL-6. The relation between the dietary pattern and CRP remained true after adjustment for 
waist circumference.25 
One limitation discussed by the authors was the assumptions that were made when 
constructing the food groups e.g. mixed food dishes and soups. Another limitation was the 
way in which information was collected from participants, the food frequency questionnaires. 
The authors’ acknowledged that is was very subjective, but thought that by using food groups 
it helped reduced subjectability.25   
ATTICA Study 
 In this cross-sectional study,26 investigators evaluated the effects of a Mediterranean 
diet on plasma levels of CRP, white blood cell count, IL-6, tumor necrosis factor (TNF)-
alpha, amyloid A, fibrinogen, and homocysteine. The study was conducted in Attica, a 
province in Greece. The time frame was from May 2001 to December 2002, and included 
3042 participants, which were randomly selected. Exclusion criteria included: history of 
CVD, atherosclerotic disease, chronic viral infections, an active cold or flu, acute respiratory 
infections, dental problems, or any surgery in the past week.26 
 Each participant’s diet was evaluated using an FFQ, which measured daily or weekly 
intake of food items. The following is what the researchers considered the Mediterranean 
diet: daily consumption of non-refined cereals and products, fruits (4-6 servings/d), 
vegetables (2-3 servings/d), olive oil, and non-fat or low-fat dairy products (1-2 servings/d); 
weekly consumption of fish, poultry, potatoes, olives, pulses, nuts (4-6 servings/week), eggs, 
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sweets (1-3 servings/week), red meat and meat products (4-5 servings/month); moderate 
consumption of red wine (1-2 glasses/day); moderate fat consumption; and a high 
monounsaturated to saturated fat ratio.26  
 Using the Mediterranean pattern described, researchers calculated each participant’s 
Mediterranean diet score. This score is a number between 0-55 that represents the 
participant’s adherence or non-adherence to the diet. The higher the number, the more 
adherent the participant was. In addition to diet, researchers also gathered information on 
annual income, education level, smoking status, and physical activity. Blood samples were 
collected and processed and analyzed in similar manners.26 
 Researchers found that participants who were in the highest tertile of the diet score 
(diet score between 36-55) had, on average, 20% lower CRP, 17% lower IL-6, 15% lower 
homocysteine, 14% lower white blood cell counts, and 6% lower fibrinogen levels when 
compared to those in the lowest tertile. This was still true even after adjusting for age, 
gender, smoking, physical activity, financial and education status, BMI, hypertension (HTN), 
DM, hypercholesterolemia, family history or CHD.26 
 One limitation of the study, as discussed by the authors, was misreporting of food 
items consumed, especially alcohol consumption. Another limitation was that the researchers 
did not complete the dietary analysis for each nutrient component.26  
McDougall et al  
 In this single-blinded dietary intervention study,27 the researchers evaluated the 
effects of a very low-fat, vegan diet on patients with RA. The study included 24 participants 
all with either moderate or severe arthritis and was conducted over 4 weeks. None of the 
participants were on a vegan or dairy-free diet prior to beginning the study, all were on stable 
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doses of medication, and all were free of CVD, DM, HTN, cancer and other serious chronic 
diseases.27 
 At baseline, blood was collected, and a rheumatologist assigned each patient a 
composite score based on joint swelling and tenderness by examining each participant. The 
lower the score the less severe the joint involvement. Laboratory test included: CRP, 
erythrocyte sedimentation rate (ESR), and RA factor.27 
 Each participant’s dietary intake was evaluated using a 4-day record and a weekly 
food-monitoring checklist. A dietitian provided guidance to each participant. Each week, for 
4 weeks, a meeting was held to teach the participants about a low-fat, vegan diet. The diet 
contained no animal products (milk, meat, cheese, eggs, etc.) or added oils and fats. Menus 
and recipes were provided to each patient and assistance with shopping and meal planning 
was given.27 
 At the conclusion of the study, blood was collected again, and ESR, CRP, and RA 
factor were again measured. Investigators found that there was no significant change in CRP 
levels. Baseline CRP was 2.08 +/- 1.8 mg/dL. At the conclusion of the 4 weeks study, CRP 
levels were 1.74 +/-1.7 mg/dL p>0.05. ESR remained unchanged, and the RA factor showed 
a non-significant change. Despite no laboratory evidence, investigators did find that 
participants had a decrease in pain, joint tenderness, swelling, and morning stiffness and an 
increase in functionality.27 
 The only limitation discussed by the authors was the lack of a control group.27 
DISCUSSION 
 
Current research is showing the importance of inflammatory biomarkers, mainly 
CRP, in connection with both heart disease and type II DM.4 Elevated CRP levels are also 
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beginning to show neurochemical changes linked to the development of cognitive 
impairment later in life.16 This systematic review shows a relationship between diet and 
increased levels of CRP, which may play a promising role in decreasing the incidence of 
certain chronic diseases.  
Two studies26,27 have shown, with consistency, that patients on a Mediterranean diet 
have statistically lower CRP levels compared to patients not on a Mediterranean diet. This 
was true for patients who were in good health,26 as well as those with metabolic syndrome.22 
One study22 found a significant drop in the number of patients with metabolic syndrome after 
two years on the Mediterranean diet with a number-needed-to-treat (NNT) of 3. (See 
Esposito et al22 in Table 2 and Table 3.) In addition, individuals who consumed diets with 
higher intakes of fruits, vegetables, legumes, whole grains, fish, and poultry had significantly 
lower CRP levels compared to individuals to ate diets high in red meat, processed meat, 
refined grains, sweets, desserts, French fries, and high-fat dairy products.24,25 (See Table 4 
and 5.)   
The use of a vegan diet to decrease CRP levels and symptomatology in RA patients 
was evaluated by two different studies.23,27 The first study23 showed that a gluten-free, vegan 
diet was also shown to have statistically lower CRP levels compared to individuals on a non-
vegan diet. In the same study, investigators also proved that a gluten-free, vegan diet lowered 
BMI, low density lipoprotein (LDL), and increased natural atheroprotective antibodies 
against phosphorylcholine (anti-PCs) compared to the non-vegan group in which anti-PCs 
decreased. Conversely, the second study27 showed that while there was a decrease in CRP 
levels in patients who ate a very low-fat, vegan diet that these levels were not statistically 
significant (See Elkan et al23 and McDougall et al27 in Table 2).  
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There are two reasons why these studies may have yielded different results. The first 
may be partially due to the limitations of the Elkan et al study,23 in which groups were not 
prognosically balanced at the start of the trial. The vegan group had a total of 30 participants, 
of which 18 were on glucocorticoids. However, out of the 28 patients in the non-vegan 
group, only nine were on glucocorticoids. And the second, in the McDougall et al27 study 
which did not show a statistically significant decrease in CRP at the conclusion of the trial, 
was the short duration of the trial, four weeks. Important to note that although CRP levels did 
not change, patients on the very low-fat, vegan diet did experience reduction in RA 
symptoms.27 Patients saw statistically significant reductions in pain, limitations of 
functionality, joint tenderness, joint swelling, and morning stiffness in both trials.23,27 
In addition to CRP, other markers of inflammation and endothelial dysfunction such 
E-selctin24,25, IL-622,24-26, sICAM-124,25 , sVCAM-124 , WBC,26 fibrinogen,26 and 
homocystein25,26 were also evaluated. Also, total cholesterol22-24,26 was measured. The 
Mediterranean diet and diets high in fruits, vegetables, whole grains, legumes, fish and 
poultry were associated with lower levels of E-selectin, IL-6, sICAM, sVCAM, and 
homocysteine.22,24-26 The Mediterranean diet was also associated with lower levels of 
fibrinogen and WBC count.26 The Mediterranean, vegan diets, and diets high in fruits, 
vegetables, whole grains, legumes, fish and poultry were associated were associated with 
significantly decreased cholesterol.22-24,26 
Limitations of the Studies  
 Limitations of all studies were reviewed and summarized. (See Table 1).  To begin, 
the randomized control trial, Esposito et al22 had very few limitations.  There is a concern for 
the difficulty of compliance to a diet, such as the Mediterranean diet, but this is a common 
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issue for any dietary intervention.  There was a good sample size, 180 participants, and 
appropriate randomization. The two groups were prognostically balanced. Proper blinding 
was maintained, concealment was done, and loss to follow-up was 9% (n=16, 8 from the 
intervention group and 8 from the control group). A larger population in both groups would 
have been preferred. No areas for risk of bias could be theorized; therefore this study is of 
high quality. 
The randomized controlled trial Elkan et al study23 had only 38 patients assigned to 
vegan diet group and 28 patients assigned to the non-vegan diet control group. Loss to 
follow-up was significant, which was evidenced by 42% of the patients in the vegan diet 
group dropping out before the conclusion of the trial. There was no loss to follow-up in the 
control group. At the start of the trial, groups were not prognostically balanced at the 
beginning of the trial in regards to patients using glucocorticoids. The vegan group contained 
60% (n=18) of participants were on glucocorticoids at the start of the trial compared to 32% 
(n=9) in the non-vegan group. This was despite the use of randomization.  
All three cross-sectional studies24-26 were all limited due to the respected researchers 
use of FFQ’s. Through the use of FFQ’s, all the studies were highly vulnerable to recall bias. 
In addition to recall bias, the use of FFQ’s allows the researchers flexibility when it comes to 
interpretations of certain food items, e.g. mixed dishes. Although the Lopez-Garcia et al24 
was conducted over 4 years, researchers failed to measure serum CRP levels at the beginning 
of the trial, choosing to only collect samples at the conclusion. This trial24 also failed to 
screen patients for current medication use, which may have resulted in biased results.  
 The McDougall et al study27 was a single-blinded interventional study. The first 
limitation was the extremely small population (n=24). Compliance was high, as evidenced by 
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22 of the 24 participants completing the four-week trial. A larger study population would be 
preferred, as would a longer trial length. The use of a control group would also be preferred.  
The quality of each study was assessed utilizing the GRADE assessment tool. (See 
Table 1.) Esposito et al22 was of high quality while all the other studies were downgraded to 
very low23-27 due to the limitations identified. Overall, the quality of evidence is a low. 
Further research examining the role of diet on serum levels of CRP, as well as other 
biomarkers of inflammation, are needed. The use of blinded, randomized control trials is 
preferred. Food frequency questionnaires should not be used due to the likelihood of recall 
bias. Steps should be taken to minimize issues with compliance such as frequent follow-ups 
and education. Further research is needed to determine the exact role of CRP in CHD, DM, 
AD, and cognitive decline.  
CONCLUSION  
 Though overall GRADE for this systematic review was low to very low, a 
recommendation can still be made to put all patients on a Mediterranean style diet regardless 
of health status as it is a simple, low-cost, self-administered, and safe intervention. This is 
especially important for patients with metabolic syndrome or any patient at-risk for CHD or 
type II DM. Placing a patient on a Mediterranean style diet will not only help with 
cholesterol levels but may also be beneficial to in decreasing cognitive decline later in life. 
Furthermore, it can be recommended that patients with RA be placed on a vegan diet. 
Another consideration is if patients with RA are non-compliant with a vegan diet, then a 
recommendation that they try a Mediterranean style diet is reasonable.  Since dietary changes 
falls under the category of preventative medicine, future research is likely and hopeful, as the 
link between inflammation and chronic disease needs to be more established. 
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No bias likely  Very Low Important  
A Groups were not prognostically balanced at start of trial. The vegan group contained 60% (n=18) of participants were on glucocorticoids at the start of the trial compared to 32% (n=9) in 
the non-vegan group.  
B Significant loss to volume up (42% in the vegan group) and small sample size (n=66) 
C Study design is vulnerable due to high probability recall bias. Food frequency questionnaires are subjective and allow researchers flexibility with interpretation. 
DSerum CRP levels were not measured at baseline. Subjects were not screened for current medication use.  
E Study design is vulnerable due to high probability recall bias. . Food frequency questionnaires are subjective and allow researchers flexibility with interpretation. 
F Study design is vulnerable due to high probability recall bias. . Food frequency questionnaires are subjective and allow researchers flexibility with interpretation. 
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Table 2 









HVegan diet patients    K Control diet patients 
I Non vegan diet patients  L All patients 
JInterventional diet patients     
 
Table 3  
Circulating levels of CRP by Tertile of the Mediterranean Diet Score26 
 
Biomarker of inflammation 1st (0-20) 2nd (21-35) 3rd (36-55) P Value 
CRP 2.0 +/- 1.8 1.8 +/- 2.1 1.6 +/-1.5 .01 
 
 
Table 4  
Circulating Levels of CRP across quintiles (Q) of dietary pattern scores25 
 
Factor  Q1 Q2 Q3 Q4 Q5 P value  
1: Fats and 
processed 
meats  
1.52 +/- 1.04 1.71 +/-1.04 1.81 +/-1.04 1.99 +/- 1.04 2.02 +/-1.05 <.001 
2: Vegtables 
and fish  
1.75 +/-1.04 1.90 +/- 1.04 1.82 +/- 1.04 1.81 +/- 1.04 1.73 +/- 1.04 .31 
3: Beans, 
tomatoes, and 
refined grains  
1.70 +/- 1.04 1.74 +/- 1.04 1.80 +/- 1.04 1.93 +/- 1.04 1.84 +/- 1.04 .09 
4: whole grains 
and fruit  
1.96 +/- 1.04 1.99 +/- 1.04 1.80 +/- 1.04 1.74 +/- 1.04 1.55 +/- 1.04 <.001 
Study Baseline 4 weeks  3 months  12 months  24 months  P value  
Elkan et alH 13 (6-26) - 11 (5-29) 5 (4-20) - .008 
Elkan et alI 22 (5-32) - 10 (5-33) 12 (4-19) - .28 
Esposito et alJ 2.8 (.7-5.4) - - - 1.7 (.04-4.9) .01 
Esposito et alK 2.9 (.5-5.7) - - - 2.8 (.5-5.5) .12 
McDougall et alL 2.08 +/- 1.8 1.74 +/- 1.7 - - - >.05 
